Sort by
Refine Your Search
-
Environment PHYSICAL DEMANDS: Computer data input required. Ability to use computing resources and perform bench-laboratory experiments. WORK ENVIRONMENT: Laboratory environment. Universal precautions
-
T-cell Acute Lymphoblastic Leukemia (T-ALL) using mouse models under the supervision of the Principal Investigator. The Postdoctoral Associate also performs research, experiments, and laboratory
-
would be expected to participate in regular research team meetings, relevant national and international research conferences, and lead the preparation of high-quality original research manuscripts
-
materials, intervention resources, and education and policy-relevant deliverables. Leads and supports implementation of cancer prevention and control studies among high-risk and underserved populations
-
Sahoo and perform molecular/cellular studies of neuronal development using in vivo (mouse models) and in vitro (cultured primary neurons) models, involving skilled surgical procedures on mice and rats
-
under supervision. These metabolites include but are not limited to oxidized lipid derivatives. The candidate will also perform statistical analyses to provide further insight into the biological roles
-
for peri-implant disease, periodontal disease, and chronic low-grade inflammation. Essential Duties and Responsibilities include the following: Design and perform experiments focused on gene and protein
-
interested in how viral and microbial factors modulate host receptors, immune responses, and metabolic pathways. The Post‑Doctoral Associate will lead independent projects, perform in vivo and in vitro
-
freezers, microscopes, centrifuges, gel electrophoresis, electroporators, qPCR thermal cyclers, and computers. Physical Demands and Work Environment Be capable of working in a biosafety cabinet for several
-
of the Principal Investigator the Post doctoral Associate will perform research. The Altindis Lab studies viral insulin/IGF‑1‑like peptides (VILPs) – sequences encoded by viruses that mimic human insulin and IGF‑1